Lithium Ion

Lithium Ion

SCHEMBL7706192

COc1ccc2c(c1)CC[C@H](CN(C)CC(=O)[O-])[C@@H]2c1ccc(F)c(F)c1.[Li+]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.64
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HSD17B2 P37059 2/20 0.38
CA1 P00915 5/20 0.37
CA2 P00918 5/20 0.37
CA9 Q16790 3/20 0.37
CA14 Q9ULX7 3/20 0.37
RORC P51449 1/20 0.36
PPARD Q03181 2/20 0.36
TAS2R14 Q9NYV8 1/20 0.35
NQO2 P16083 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
ACHE P22303 2/20 0.35
CA7 P43166 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7706037 0.91 SLC6A9 (0.69) SLC6A9HSD17B2CA1CA2CA9
Lithium Ion SCHEMBL7703313 0.90 SLC6A9 (0.74) SLC6A9HSD17B2CA1CA2CA9
Org-25935 SCHEMBL7703028 0.87 SLC6A9 (0.85) SLC6A9CA1CA2CA9CA14
Org-25935 SCHEMBL7704305 0.87 SLC6A9 (0.85) SLC6A9CA1CA2CA9CA14
Lithium Ion SCHEMBL7704515 0.86 SLC6A9 (0.60) SLC6A9HSD17B2CA1CA2RORC
Lithium Ion SCHEMBL7705019 0.81 SLC6A9 (0.56) SLC6A9CA1CA2CA9CA14
Lithium Ion SCHEMBL7698371 0.80 SLC6A9 (0.53) SLC6A9MTNR1AMTNR1B
Lithium Ion SCHEMBL7698462 0.79 SLC6A9 (0.69) SLC6A9PPARDMTNR1AMTNR1B
Lithium Ion SCHEMBL7706983 0.79 SLC6A9 (0.71) SLC6A9TAS2R14NQO2MTNR1AMTNR1B
Org-25935 SCHEMBL7703430 0.78 SLC6A9 (1.00) SLC6A9CA1CA2CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed